Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

ICF-Based Effects of PNF and Kinesio Taping on Hand Function in Hemiplegic Stroke

NCT07014696 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-06-01
Last updated
2026-01-15

Condition(s) studied

HemiplegiaHemiplegia Due to StrokeHand FunctionalityUpper ExtremityProprioceptive Neuromuscular FacilitationKinesio Taping

Investigational drug(s) / intervention(s)

PNF application GroupKB application GroupPNF+KB application Group

PNF application Group: PNF Application; in the application method, the subjects will be in a sitting position. The application will be made to the fingers, wrist and forearm in both D1 and D2 directions in flexion and extension patterns. The techniques will start using rhythmic initiation, then the combination of isotonics, dynamic-opposite, rhythmic stabilization and muscle-relaxation are determined. The movements will be made in 10 repetitions with rest in between (Saklecha et al., 2023).

KB application Group: KB Application; In the taping treatment to be applied, taping will be applied starting from the fingers and up to the elbow with kinesiology taping (Huang et al., 2019). Taping will be done 3 days a week and the tape will remain on the patient for 2 days.

PNF+KB application Group: PNF+ KB Application; In this application, both PNF and taping will be applied. After each application, conventional treatment will be applied to all three groups at the end of each session. When all treatments are completed, re-evaluations will be made by the blind physiotherapist

Study summary

This clinical trial aims to compare the effects of kinesio taping and PNF on hemiplegic hand functions. In addition, the effects of these applications on body structure, activity, and participation will be examined. The main questions it aims to answer are:

Do kinesio taping and PNF applications have different effects on hemiplegic hand function? Are kinesio taping and PNF applications effective in body structure, activity, and participation? The researchers will compare the advantages of kinesio taping and PNF applications over each other.

Participants:

Kinesio taping and/or PNF applications will be applied 3 days a week for 8 weeks.

Tests will be performed on the first and last day of the study to evaluate hand functions.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:Inclusion criteria for the study (Junior et al., 2019; Kim \& Kim, 2015; Saklecha et al., 2023) * Stroke diagnosed by MRI or CT, regardless of ischemic or hemorrhagic origin, * Hemiplegia caused by stroke alone, * At least 6 and at most 24 months have passed since the stroke was diagnosed * Being over 18 years of age, * Volunteering to participate in the study * Scoring 24 or more on the Standardized Mini Mental State Examination (if illiterate, scoring 18 or more is sufficient) * Cooperating with evaluation, tests and treatment * Understanding and speaking Turkish * Being at least stage 4 according to Brunnstrom staging Exclusion Criteria: * Exclusion Criteria (Junior et al., 2019; Kim \& Kim, 2015; Saklecha et al., 2023) * Individuals with bilateral hemiplegia * Individuals with unstable vital signs * Individuals with any open wound in the upper extremity * Pathological conditions affecting upper extremity sensation (undergoing surgery after fracture, etc.) * Individuals with a BMI value greater than 29.9 kg/m2 * Individuals with a Standardized Mini Mental Test score below 24 points (18 points) * Individuals with major neurological or rheumatological disorders affecting the musculoskeletal system other than stroke (Polyneuropathy, Parkinson's, Multiple Sclerosis, Rheumatoid Arthritis, etc.) * Presence of upper extremity amputation * Being at less than stage 4 according to Brunnstrom staging

Primary outcome measure(s)

  • The Fugl Meyer assessment — Beginning of the study and end of week 8 (when 24 sessions are completed)
    The Fugl Meyer assessment scale is a stroke-specific, performance-based scale, and each parameter is scored as 0; unsuccessful, 1; partially successful, and 2; completely successful performance. In the shoulder, elbow, and forearm, reflex activity, voluntary movements performed with dynamic flexor and/or extensor synergies, voluntary movements performed using dynamic flexor and extensor synergies together, voluntary movements performed without or with very little dependence on synergies, and normal reflex activity parameters are evaluated. When evaluating the wrist, three different functions of the wrist muscles are evaluated. In the hemiplegia hand evaluation, 7 movements (flexion, extension, and five grip functions) are evaluated. In the coordination/speed evaluation, a finger-nose test is performed for the upper extremity. During this test, tremor, dysmetria, and speed of movement are evaluated. The maximum motor performance score for the upper extremity is 66 points.
  • Action Research Arm Test (ARAT) — Beginning of the study and end of week 8 (when 24 sessions are completed)
    The ARAT observes arm and hand movements during the performance of a variety of reaching and grasping tasks. It measures the ability to qualitatively manipulate and carry large or small objects in relation to manual dexterity and proximal strength for the upper extremity. The ARAT rates the upper extremity on a 4-point scale (maximum of 57 points for each upper extremity): 3 points if the task is performed normally; 2 points if the task is completed but takes an abnormally long time; 2 points if performed with great difficulty or poorly coordinated movements; 1 point if the task is only partially completed; and 0 points if the task is not performed at all.
  • The Box-Block Test — Beginning of the study and end of week 8 (when 24 sessions are completed)
    The Box-Block Test measures unilateral manual dexterity. It is a fast, simple and inexpensive test. It can be used in a wide variety of diseases, including stroke patients. It consists of a box divided into two and 150 blocks. The wooden blocks are cubes measuring 2.5 cm x 2.5 cm x 2.5 cm. The barrier in the middle of the box is 15.2 cm. Patients are asked to throw the blocks from one section to the other, one by one, within 60 seconds and the number of blocks is recorded.
  • Nine hole Peg Test — Beginning of the study and end of week 8 (when 24 sessions are completed)
    It is a simple and quick test used to evaluate changes in hand functions. The participant is asked to insert nine rods into a wooden block with nine holes as quickly as possible and then remove them. The test is repeated twice and the score is determined as the average of the two trials. The participant is expected to perform the test with the hand on the affected side of the body.

Trial sites (2)

FacilityCityRegionStatus
İstinye University, Bahçeşehir Liv Hospital Istanbul Bahçeşir Recruiting
Ondokuz Mayıs Üniversitesi, SUVAM Havza Fizik Tedavi ve Rehabilitasyon Merkezin Samsun Havza Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07014696 on ClinicalTrials.gov ↗ ← All trials in Turkey